Why didn’t #AVCT add those two additional indications to the clinical trial before the phase 1a trial began, if the decision to add was based upon pre-clinical and Tempus data they were already in possession of?
Think timeline mentioned would suggest this The AACR Annual Meeting 2026 will take place in San Diego, California, from April 17 to April 22, 2026, featuring the latest breakthroughs in cancer research.
Might be barking up wrong tree, but wasn't someone who called himself something like matt Damon a regular poster back then, think he said he was a builder from Liverpool.